Form 8-K - Current report:
SEC Accession No. 0001104659-25-008100
Filing Date
2025-01-31
Accepted
2025-01-31 16:06:14
Documents
13
Period of Report
2025-01-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254971d1_8k.htm   iXBRL 8-K 29864
  Complete submission text file 0001104659-25-008100.txt   205802

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pasg-20250129.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20250129_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20250129_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm254971d1_8k_htm.xml XML 3826
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 25578401
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)